Photos: 

Some evaluation reports are public and can be downloaded from this website, while others are restricted to MSF users and can only be accessed via Tukul. This limitation is mainly due to the sensitive nature of the operational contexts and the resulting content. However, there are internal discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

This end of project evaluation of the Roma and Semongkong project “Reducing maternal and infant morbidity and mortality in a hyper-epidemic HIV/TB setting” in Lesotho was commissioned by the MSF Operational Centre Brussels (OCB) South Africa & Lesotho mission to evaluate the impact of the five years programme and identify lessons learned to support the design and planning of potential future projects in Lesotho.

This evaluation was conducted by Heidi Becher and Timothy McCann, on behalf of the Stockholm Evaluation Unit of MSF. This publication was produced at the request of MSF OCB, under the management of the Stockholm Evaluation Unit. It was prepared independently by heidi Becher and Timothy McCann.
30/12/2015

Chemical prevention of seasonal malaria (CPS) has been implemented in Niger since 2013, pursuant to the recommendations of the World Health Organization (WHO) and the national anti-malaria policy. It consists of a mass campaign involving the administration of curative doses of sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) to children between the ages of 3 and 59 months for three days, at 28-day intervals, between July and November.

Alena Koscalova
29/09/2015

La chimio-prévention du paludisme saisonnier (CPS) a été mise en œuvre au Niger depuis 2013, conformément aux recommandations de l'Organisation mondiale de la Santé (OMS) et à la politique nationale de lutte contre le paludisme. Elle se déroule sous la forme d’une campagne de masse qui consiste en l’administration de doses curatives de sulphadoxine-pyriméthamine (SP) et d'amodiaquine (AQ) durant trois jours, à 28 jours d’intervalle entre juillet et novembre, aux enfants de 3 à 59 mois.

by Alena Koscalova
01/02/2015